CUBRC
CUBRC is an independent, not-for-profit company dedicated to research, development, testing, and systems integration, focusing on high-stakes challenges in defense, intelligence, and homeland security. With a legacy of technical excellence, CUBRC combines innovative ideas and state-of-the-art technology to address critical problems facing the nation.
Industries
Nr. of Employees
medium (51-250)
CUBRC
4455 Genesee Street, Suite 106, Buffalo, NY 14225
Awards
C. Pravibismane Suspension as a Topical, Broad Spectrum Anti-Infective...
Funding (ceiling)
$4,150,691.2
Award Year
2020
Products
Mission planning and optimization software suite
A suite of tools combining operations research algorithms, machine learning and complex-event processing to support mission planning, evaluation and semi-autonomous command-and-control workflows.
High-fidelity mission-level modeling and simulation system
Mission-level simulation software modeling integrated defense architectures for training and operational analysis.
Open-source common core ontology and domain ontologies
A BFO/ISO-based common core ontology and domain-specific ontologies provided as open-source resources to support semantic interoperability and machine-understandable data across domains.
Mission planning and optimization software suite
A suite of tools combining operations research algorithms, machine learning and complex-event processing to support mission planning, evaluation and semi-autonomous command-and-control workflows.
High-fidelity mission-level modeling and simulation system
Mission-level simulation software modeling integrated defense architectures for training and operational analysis.
Open-source common core ontology and domain ontologies
A BFO/ISO-based common core ontology and domain-specific ontologies provided as open-source resources to support semantic interoperability and machine-understandable data across domains.
Services
CUBRC operates BSL-2, BSL-3 and chemical agent test facilities. We use an array of pre-clinical and non-clinical in vitro assays and other test methodologies including ASTM and DoD Test Operation Procedures and adapt them to meet client needs while providing high-quality, defendable data sets. All of this work falls under CUBRC’s ISO 9001:2015 Quality Management System.
CUBRC leverages over 35 years of experience supporting the U.S. Government, the Chemical and Biological Defense Program, Food and Drug Administration and the Department of Health and Human Services to advance new and existing medical countermeasures (MCMs) to protect our soldiers and citizens. To achieve this, we partner with early and mid-stage pharmaceutical companies, apply our expertise in MCM development and leverage our corporate infrastructure and experience in the federal contracting and procurement domain.
CUBRC operates BSL-2, BSL-3 and chemical agent test facilities. We use an array of pre-clinical and non-clinical in vitro assays and other test methodologies including ASTM and DoD Test Operation Procedures and adapt them to meet client needs while providing high-quality, defendable data sets. All of this work falls under CUBRC’s ISO 9001:2015 Quality Management System.
CUBRC leverages over 35 years of experience supporting the U.S. Government, the Chemical and Biological Defense Program, Food and Drug Administration and the Department of Health and Human Services to advance new and existing medical countermeasures (MCMs) to protect our soldiers and citizens. To achieve this, we partner with early and mid-stage pharmaceutical companies, apply our expertise in MCM development and leverage our corporate infrastructure and experience in the federal contracting and procurement domain.
Expertise Areas
- High-containment laboratory RDT&E (BSL-2/BSL-3)
- Government proposal development and program management
- Pre-clinical assay development and virology methods
- Aerosol challenge and environmental testing
Key Technologies
- BSL-2 and BSL-3 laboratory infrastructure
- Aerosol challenge chambers and room-scale environmental test rooms
- Certified live-agent chemical test facilities
Key People
News & Updates
CUBRC, in collaboration with EpiVax, Inc., was awarded a two-year contract worth $2 million for the development of control peptides.
CUBRC announces its acquisition of Ahmic Aerospace, enhancing its capabilities in research and development.
CUBRC participates in a significant flight test program aimed at advancing hypersonic research.
Senator Schumer announces funding to boost CUBRC's operations and support the defense industry in Western New York.
CUBRC, in collaboration with EpiVax, Inc., was awarded a two-year contract worth $2 million for the development of control peptides.
CUBRC announces its acquisition of Ahmic Aerospace, enhancing its capabilities in research and development.
CUBRC participates in a significant flight test program aimed at advancing hypersonic research.
Senator Schumer announces funding to boost CUBRC's operations and support the defense industry in Western New York.